Download Our Media Kit
For patients with diabetes and healthcare professionals that want an easy-to-use
portable A1c testing device, Orange Biomed…
The Role of Corporate Social Responsibility for U.S. Market Entry and Expansion – Expediting Value Across Industries Through Community Efforts
When S. Korean companies attempt to
enter or expand within the U.S. market,
they often confront obstacles due to their…
Orange Biomed acquires ISO 9001 certification for quality management system
Glycated hemoglobin, a glycated protein in which sugar is bound to hemoglobin in red blood cells, is the most important…
CEO Interview: Orange BioMed Revolutionizes Diabetes Management: HbA1c Measurement with a Drop of Blood
Glycated hemoglobin, a glycated protein in which sugar is bound to hemoglobin in red blood cells, is the most important…
Orange Biomed selected as 2023 “First Penguin ” by Korea Credit Guarantee Fund
Orange Biomed, a venture company developing a microfluidic-based glycated hemoglobin measurement medical device…
A New Portable HbA1c Meter—Red Blood Cell Deformability–Based HbA1c Test
In the United States, more than 1 in 5 people with diabetes do not know they have diabetes, and they are at higher risk…
Orange Biomed Reveals Home A1c Test in U.S.
Orange Biomed, a diabetes management tech startup, has launched its OBM rapid A1c test in the U.S.
OBM rapid A1c…
Portable, Pocket-Sized A1c Testing Device Delivers Results in 5 Minutes From Single Blood Drop
Diabetes stands as a primary contributor to mortality rates and accounts for a significant portion of healthcare expenses…
Orange Biomed launches OBM rapid A1c test in the US
Healthcare start-up Orange Biomed has launched its pocket-sized, reusable OBM rapid A1c test in the US to fill the testing…
Diabetes Startup Firm Orange Biomed Launches in U.S.
South Korean startup Orange Biomed announced Wednesday its US launch with…